Training future scientists in cancer research
Translational Cancer Biology (TCB) T32 Training Program
['FUNDING_TRAINING'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-10933876
This program is designed to help new researchers learn how to turn exciting lab discoveries about cancer into real treatments, so they can work together and use the latest tools to make a difference in the fight against cancer.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-10933876 on ClinicalTrials.gov |
What this research studies
This program focuses on training pre-doctoral and post-doctoral researchers in the field of cancer biology, emphasizing the transition from laboratory discoveries to clinical applications. Participants will engage in hands-on research, learning about the latest advancements in cancer treatment and the importance of rigorous experimental design. The program also includes training in multidisciplinary teamwork, systems biology, and data analysis, preparing trainees for careers in both academic and industrial settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals pursuing advanced degrees in cancer biology or related fields who are interested in a career in cancer research.
Not a fit: Patients who are not involved in academic or research training programs may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative cancer treatments and improved patient outcomes.
How similar studies have performed: Previous training programs in cancer biology have shown success in producing skilled researchers who contribute significantly to advancements in cancer treatment.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BREKKEN, ROLF A — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: BREKKEN, ROLF A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology